Italia markets close in 3 hours 42 minutes

Alphabet Inc. (GOOG)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
101,43+1,56 (+1,56%)
Alla chiusura: 04:00PM EST
106,05 +4,62 (+4,55%)
Preborsa: 07:48AM EST
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente99,87
Aperto99,74
Denaro0,00 x 1400
Lettera0,00 x 900
Min-Max giorno98,43 - 102,19
Intervallo di 52 settimane83,45 - 149,12
Volume26.392.568
Media Volume25.697.870
Capitalizzazione1,306T
Beta (5 anni mensile)1,07
Rapporto PE (ttm)20,41
EPS (ttm)4,97
Prossima data utili24 apr 2023 - 28 apr 2023
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1A122,30
  • CoinDesk

    Tech’s Money Woes: Beginning of the End for Web2?

    Gloomy forecasts, mass layoffs and antitrust lawsuits have bruised "Big Tech" over the past year. But that doesn't automatically portend the end of Web2. For Web3 to emerge, we have to address key questions about AI and decentralization.

  • GlobeNewswire

    Purpose Investments Debuts Yield Shares, the World’s First Yield-Focused Single-Stock ETFs

    Yield Shares seek to provide investors with enhanced* monthly distributions from individual stocks of world-class companiesTORONTO, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Purpose Investments Inc. (“Purpose Investments”), a modern investment firm known for its globally innovative, client-centric products, is excited to announce the launch of Yield Shares by Purpose (“Yield Shares”), as described in the table below, the world’s first yield-focused single-stock ETFs, which will begin trading today on th

  • GlobeNewswire

    RadNet’s Aidence Artificial Intelligence (AI) Subsidiary and Google Health Enter into Collaboration to Help Improve Lung Cancer Screening with AI Solutions

    LOS ANGELES, Nov. 28, 2022 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services today reported that its lung artificial intelligence subsidiary, Aidence, and Google Health, a division of Alphabet, Inc. (NASDAQ: GOOG), announce an agreement to license Google Health’s AI research model for lung nodule malignancy prediction on CT imaging. Aidence will develop, validate and bring this model to